1023 related articles for article (PubMed ID: 9090379)
21. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
Tsao H; Zhang X; Benoit E; Haluska FG
Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
[TBL] [Abstract][Full Text] [Related]
22. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.
Whang YE; Wu X; Sawyers CL
J Natl Cancer Inst; 1998 Jun; 90(11):859-61. PubMed ID: 9625175
[No Abstract] [Full Text] [Related]
23. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.
Yokomizo A; Tindall DJ; Drabkin H; Gemmill R; Franklin W; Yang P; Sugio K; Smith DI; Liu W
Oncogene; 1998 Jul; 17(4):475-9. PubMed ID: 9696041
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer.
Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH
Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
[TBL] [Abstract][Full Text] [Related]
26. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles.
Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M
Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
[TBL] [Abstract][Full Text] [Related]
29. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D
Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969
[TBL] [Abstract][Full Text] [Related]
30. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
[TBL] [Abstract][Full Text] [Related]
32. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
[TBL] [Abstract][Full Text] [Related]
33. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
[TBL] [Abstract][Full Text] [Related]
34. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
[TBL] [Abstract][Full Text] [Related]
35. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
36. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas.
Butler MP; Wang SI; Chaganti RS; Parsons R; Dalla-Favera R
Genes Chromosomes Cancer; 1999 Apr; 24(4):322-7. PubMed ID: 10092130
[TBL] [Abstract][Full Text] [Related]
37. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
38. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.
Furnari FB; Lin H; Huang HS; Cavenee WK
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12479-84. PubMed ID: 9356475
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
40. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
